PGAa

General Information


DRACP ID  DRACP03700

Peptide Name   PGAa

Sequence  GILSKLGKALKKAAKHAAKA

Sequence Length  20

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C91H166N28O22

Absent amino acids  CDEFMNPQRTVWY

Common amino acids  AK

Mass  234361

Pl  11.5

Basic residues  7

Acidic residues  0

Hydrophobic residues  10

Net charge  7

Boman Index  -894

Hydrophobicity  -7.5

Aliphatic Index  108

Half Life 
  Mammalian: 1.4 hour
  Yeast: 3 min
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 9428709

Title  Design of Synthetic peptide antimicrobial peptides based on sequence analogy and amphipathicity

Doi Not available

Year  1997

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  11380

DRACP is developed by Dr.Zheng's team.